chitosan has been researched along with atenolol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Lennernäs, H; Ocklind, G; Schipper, NG; Stenberg, P; Vârum, KM | 1 |
| Bhatia, MS; Kumbhar, ST; Patil, SS | 1 |
2 other study(ies) available for chitosan and atenolol
| Article | Year |
|---|---|
Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Biocompatible Materials; Biological Transport; Caco-2 Cells; Cell Membrane Permeability; Chitin; Chitosan; HT29 Cells; Humans; Ileum; Intestinal Absorption; Intestinal Mucosa; Male; Mucus; Perfusion; Rats; Rats, Sprague-Dawley | 1999 |
In silico design and pharmacological evaluation of conjugates of atenolol with modified saccharide for cardiovascular targeting.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Artemia; Atenolol; Cell Line; Chitosan; Computer Simulation; Drug Carriers; Drug Evaluation, Preclinical; Galactose; Glucose Transporter Type 4; Lethal Dose 50; Magnetic Resonance Spectroscopy; Myocardium; Pectins; Rats; Spectroscopy, Fourier Transform Infrared | 2021 |